ArticleBreast cancer research and treatment2021

Heregulin-induced cell migration is prevented by trastuzumab and trastuzumab-emtansine in HER2+ breast cancer.

Joselina Magali Mondaca et al.PubMed ↗Publisher ↗

No numbers read from the abstract.